The 76-gene signature defines high-risk patients that benefit from adjuvant tamoxifen therapy - Concepedia

Concepedia

Publication | Open Access

The 76-gene signature defines high-risk patients that benefit from adjuvant tamoxifen therapy

DOI Full Paper Access

154

Citations

22

References

2008

Year

Yi Zhang, Anieta M. Sieuwerts, Michelle McGreevy, Graham Casey, Tanja Čufer, Angelo Paradiso, Nadia Harbeck, Paul N. Span, David G. Hicks, Joseph P. Crowe,

Breast Cancer Research and Treatment

Breast OncologyOncology76-Gene SignatureEndocrine-related CancerMedicineAdjuvant Tamoxifen TherapyGenetic EpidemiologyImmunologyPathologyBreast CancerHigh-risk PatientsCancer GeneticsMolecular DiagnosticsCancer ResearchVariant Interpretation

References

	Year	Citations

Page 1

Page 1